PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CDC COVID-19 Response Team, 1600 Clifton Rd. NE, Mailstop H23-6, Atlanta, GA, USA. pfx6@cdc.gov.\', \'Laboratory Leadership Service, CDC, Atlanta, GA, 30329, USA. pfx6@cdc.gov.\', \'CDC COVID-19 Response Team, 1600 Clifton Rd. NE, Mailstop H23-6, Atlanta, GA, USA.\', \'Epidemic Intelligence Service, CDC, Atlanta, GA, 30329, USA.\', \'Wisconsin Department of Health Services, Madison, WI, 53703, USA.\', \'School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.\', \'University Health Services, University of Wisconsin-Madison, Madison, WI, 53705, USA.\', \'Agency for Toxic Substances and Disease Registry (ATSDR), CDC, Atlanta, GA, 30341, USA.\', \'Laboratory Leadership Service, CDC, Atlanta, GA, 30329, USA.\', \'Wisconsin State Laboratory of Hygiene, Madison, WI, 53718, USA.\', \'University of Wisconsin-Oshkosh, Oshkosh, WI, 54901, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12879-022-07314-5
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 35361140
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
?:title
  • A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all